000 01639 a2200517 4500
005 20250513030906.0
264 0 _c19940623
008 199406s 0 0 eng d
022 _a0027-5107
024 7 _a10.1016/0165-1161(94)00016-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTice, R R
245 0 0 _aReport from the working group on the in vivo mammalian bone marrow chromosomal aberration test.
_h[electronic resource]
260 _bMutation research
_cJun 1994
300 _a305-12 p.
_bdigital
500 _aPublication Type: Consensus Development Conference; Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBone Marrow
_xdrug effects
650 0 4 _aBone Marrow Cells
650 0 4 _aChromosome Aberrations
650 0 4 _aData Interpretation, Statistical
650 0 4 _aDocumentation
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGuidelines as Topic
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMutagenicity Tests
_xmethods
650 0 4 _aMutagens
_xtoxicity
650 0 4 _aPharmaceutical Vehicles
650 0 4 _aRats
650 0 4 _aReproducibility of Results
650 0 4 _aResearch Design
650 0 4 _aSex Factors
700 1 _aHayashi, M
700 1 _aMacGregor, J T
700 1 _aAnderson, D
700 1 _aBlakey, D H
700 1 _aHolden, H E
700 1 _aKirsch-Volders, M
700 1 _aOleson, F B
700 1 _aPacchierotti, F
700 1 _aPreston, R J
773 0 _tMutation research
_gvol. 312
_gno. 3
_gp. 305-12
856 4 0 _uhttps://doi.org/10.1016/0165-1161(94)00016-6
_zAvailable from publisher's website
999 _c7514208
_d7514208